Third Pole Therapeutics
PrivateLast Round
Series B
Feb 12, 2024
Total Funding Raised
$72M
Momentum Score
50 /100
Company Overview
Third Pole Therapeutics is a medical device company that develops an innovative inhalation device capable of generating nitric oxide on-demand to provide life-saving therapies for various cardiopulmonary conditions, including hypoxic respiratory failure in newborns.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Health IoT
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Third Pole Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Third Pole Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 12, 2024 | ||||
| Series B | Dec 14, 2022 | ||||
| Series B | Feb 3, 2022 | ||||
| Debt | Apr 15, 2021 |
Key People
Founding team and executive leadership
Third Pole Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Heart, Lung, and Blood Institute | Series B |
| National Center for Advancing Translational Sciences | Series B |
| Saturn Partners | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 12, 2024
$55M round closed.
Third Pole Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Third Pole Therapeutics's valuation, stock price, and market status.
